Table 2 Distribution of tumour characteristics of Breast cancer cases
Characteristics | Number | Percent | |
|---|---|---|---|
Tumor subtype | Invasive Ductal Carcinoma | 338 | 75.1 |
Precursor lesions | 19 | 4.2 | |
Invasive Lobular Carcinoma | 11 | 2.4 | |
Invasive Medulary Carcinoma | 7 | 1.6 | |
Metastatic Carcinoma | 11 | 2.4 | |
Others | 13 | 2.9 | |
Unreported | 51 | 11.3 | |
Grade | Low grade (I & II) | 252 | 56 |
High grade (III) | 96 | 21.3 | |
Unreported | 102 | 22.7 | |
Tumor size | Small (I & II) | 292 | 64.9 |
Large (III & IV) | 73 | 16.2 | |
Unreported | 85 | 18.9 | |
Lymph node | Negative | 144 | 32 |
Positive (I, II & III) | 213 | 47.4 | |
Unreported | 93 | 20.4 | |
Metastasis | Negative | 338 | 75.1 |
Positive | 22 | 4.9 | |
Unreported | 90 | 20 | |
Stage | Early stage (I & II) | 128 | 50.7 |
Late stage (III & IV) | 130 | 28.9 | |
Unreported | 92 | 20.4 | |
ER status a | Negative | 101 | 22.4 |
Positive | 295 | 65.6 | |
Unreported | 54 | 12 | |
PR status b | Negative | 114 | 25.3 |
Positive | 281 | 62.4 | |
Unreported | 55 | 12.2 | |
HER2 c | Negative | 257 | 57.1 |
Positive | 103 | 22.9 | |
Equivocal | 25 | 5.6 | |
Unreported | 65 | 14.4 | |
Receptor status | ER/PR + HER2 +/- | 305 | 67.7 |
ER/PR - HER2 + | 41 | 9.1 | |
Triple negative (TNBC) | 45 | 10 | |
Unreported | 59 | 13.1 | |